Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a tertiary care hospital in Riyadh, Saudi Arabia.

Almaghrabi, Reem S; Alsagheir, Osamah I; Alquaiz, Rawan M; Alhekail, Othman Z; Abaalkhail, Abdulrahman M; Alduaij, Atheer A; Algwaiz, Ghadah F; Alkaff, Morad A; Althawadi, Sahar I

Almaghrabi, Reem S; Alsagheir, Osamah I; Alquaiz, Rawan M; Alhekail, Othman Z; Abaalkhail, Abdulrahman M; Alduaij, Atheer A; Algwaiz, Ghadah F; Alkaff, Morad A; Althawadi, Sahar I.

Afiliação

Almaghrabi RS; Department of Medicine, King Faisal Hospital and Research Centre, Riyadh, Saudi Arabia.
Alsagheir OI; Department of Medicine, King Faisal Hospital and Research Centre, Riyadh, Saudi Arabia.
Alquaiz RM; Department of Medicine, King Faisal Hospital and Research Centre, Riyadh, Saudi Arabia.
Alhekail OZ; Department of Medicine, King Faisal Hospital and Research Centre, Riyadh, Saudi Arabia.
Abaalkhail AM; Department of Medicine, King Faisal Hospital and Research Centre, Riyadh, Saudi Arabia.
Alduaij AA; Department of Medicine, King Faisal Hospital and Research Centre, Riyadh, Saudi Arabia.
Algwaiz GF; Department of Medicine, King Faisal Hospital and Research Centre, Riyadh, Saudi Arabia.
Alkaff MA; Microbiology Laboratory, Department of Pathology and Laboratory Medicine, King Faisal Hospital and Research Centre, Riyadh, Saudi Arabia.
Althawadi SI; Microbiology Laboratory, Department of Pathology and Laboratory Medicine, King Faisal Hospital and Research Centre, Riyadh, Saudi Arabia.

IJID Reg ; 2: 51-54, 2022 Mar.

Article em En | MEDLINE | ID: mdl-35721439

Palavras-chave

COVID-19; SARS-CoV-2; antibodies; asymptomatic; infection; prevalence

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google